Agent can reveal HSC engraftment faster

An imaging agent can safely show engraftment of hematopoietic stem cells (HSCs) just days after transplant, according to research published in The...

Conference Coverage

Team identifies biomarkers for cGVHD in kids

SALT LAKE CITY—Researchers say they have identified prognostic biomarkers for chronic graft-vs-host disease (cGVHD) in children. The group found...

Conference Coverage

Expanded UCB product can stand alone

SALT LAKE CITY—The expanded umbilical cord blood (UCB) product NiCord can be used as a stand-alone graft, according to research presented at the...

Conference Coverage

Regimen deemed ‘safe and feasible’ in MM

SALT LAKE CITY—A novel transplant regimen is “safe and feasible” for patients with multiple myeloma (MM), according to a presentation at the 2018...


FDA investigating VTEs related to ECP

The US Food and Drug Administration (FDA) says it is evaluating reports of venous thromboembolism (VTE) in patients treated with the CELLEX...